CLINICAL_TRIALS
trial_result
· 2007-01-09
Clinical Trial Update: A Study of BufferGel in Women [Phase 1]
Summary
A Phase 1 clinical trial evaluating the safety of BufferGel in women for HIV infection; the study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED